Day: May 7, 2026

The U.S. Food and Drug Administration recently unveiled a provocative shift in its oversight strategy by launching one-day inspectional assessments for manufacturing facilities. This program moves away from the multi-day, comprehensive deep dives that have long been the gold standard of regulatory compliance. By focusing on high-priority, risk-based indicators, the agency aims to broaden its … Read more

The Food and Drug Administration is no longer just a regulator of medicine; it is becoming a powerhouse of data science. For decades, the agency struggled under the weight of massive application backlogs and fragmented legacy systems. Today, the FDA is undergoing a digital metamorphosis, integrating sophisticated AI tools like “Elsa” to streamline how we ensure public … Read more